A detailed history of Franklin Resources Inc transactions in Nuvalent, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 194,691 shares of NUVL stock, worth $20.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
194,691
Previous 194,037 0.34%
Holding current value
$20.1 Million
Previous $14.6 Million 1.37%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$62.76 - $81.61 $41,045 - $53,372
654 Added 0.34%
194,691 $14.8 Million
Q1 2024

May 13, 2024

BUY
$72.35 - $88.99 $1.35 Million - $1.66 Million
18,601 Added 10.6%
194,037 $14.6 Million
Q4 2023

Feb 09, 2024

BUY
$42.42 - $80.28 $907,363 - $1.72 Million
21,390 Added 13.89%
175,436 $12.9 Million
Q3 2023

Nov 13, 2023

BUY
$39.12 - $49.85 $5.69 Million - $7.25 Million
145,457 Added 1693.53%
154,046 $7.08 Million
Q2 2023

Aug 11, 2023

BUY
$23.58 - $44.68 $202,528 - $383,756
8,589 New
8,589 $362,000

Others Institutions Holding NUVL

About Nuvalent, Inc.


  • Ticker NUVL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 42,977,800
  • Market Cap $4.44B
  • Description
  • Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...
More about NUVL
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.